The association of CYP2D6 *10 polymorphism with breast cancer risk and clinico-pathologic characteristics in Chinese women

Author： Li Hongxia Feng Liya Xu Ye Yao Lihua Ouyang Tao Li Jinfeng Wang Tianfeng Fan Zhaoqing Lin Benyao Li Jiyou Xie Yuntao

Publisher： Informa Healthcare

ISSN： 0284-186X

Source： Acta Oncologica, Vol.45, Iss.5, 2006-07, pp. : 597-601

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Genetic polymorphism in CYP17 and breast cancer risk in Japanese women

By Miyoshi Y. Iwao K. Ikeda N. Egawa C. Noguchi S.

European Journal of Cancer, Vol. 36, Iss. 18, 2000-12 ,pp. : 2375-2379

Elsevier

Access to resources Recommend Favorite

Concurrent use of tamoxifen with CYP2D6 inhibitors and the risk of breast cancer recurrence

By Azoulay Laurent

Breast Cancer Research and Treatment, Vol. 126, Iss. 3, 2011-04 ,pp. : 695-703

Springer Publishing Company

Access to resources Recommend Favorite

Role of CYP1A2 polymorphisms in breast cancer risk in women

By Ayari Imene Fedeli Ugo Saguem Saad Hidar Samir Khlifi Saida Pavanello Sofia

Molecular Medicine Reports, Vol. 7, Iss. 1, 2013-01 ,pp. : 280-286

Spandidos Publications

Access to resources Recommend Favorite

No association between CYP17 T-34C polymorphism and breast cancer risk: a meta-analysis involving 58,814 subjects

By Yao Lei

Breast Cancer Research and Treatment, Vol. 122, Iss. 1, 2010-07 ,pp. : 221-227

Springer Publishing Company

Access to resources Recommend Favorite

The CYP17A1 −34T > C polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers

By Kaufman Bella

Breast Cancer Research and Treatment, Vol. 126, Iss. 2, 2011-04 ,pp. : 521-527

Springer Publishing Company

Access to resources Recommend Favorite